Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Plasmodium falciparum endoperoxide activation pathway is a crucial process by which artemisinin and related endoperoxide antimalarial drugs are activated. This activation occurs in the parasite's digestive vacuole, driven by Fe(II)PPIX (heme) released during hemoglobin digestion. The heme cleaves the drug's endoperoxide bridge, generating cytotoxic carbon-centered free radicals that damage parasite proteins and membranes, leading to parasite death. The effectiveness of artemisinin depends on this pathway, and resistance can arise if parasites alter hemoglobin digestion or reduce available Fe(II)PPIX.
Fe(II)PPIX-dependent cleavage of endoperoxide bond leading to generation of cytotoxic reactive intermediates, protein alkylation and downstream damage
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Plasmodium falciparum Endoperoxide Activation Pathway (None).